Human immunodeficiency virus infection in pregnancy

Area of Science:

• Reproductive Health
• Infectious Diseases
• Immunology

Background:

• HIV infection is a growing global concern, with a significant percentage of cases occurring in adolescent and adult women.
• Transmission routes include sexual contact, needle sharing, and vertical transmission from mother to child.
• HIV does not typically impact fertility or pregnancy outcomes unless significant immune dysfunction (CD4 < 400/mm3) is present.

Purpose of the Study:

• To review the impact of HIV infection on women's health, particularly during child-bearing years.
• To discuss modes of HIV transmission and opportunistic infections in women.
• To outline current understanding and uncertainties regarding HIV management during pregnancy and prevention of mother-to-child transmission.

Main Methods:

• Literature review and synthesis of existing data on HIV in women.
• Analysis of factors influencing pregnancy outcomes in HIV-infected individuals.
• Examination of opportunistic pathogens and treatment strategies.

Main Results:

• Pregnancy generally does not worsen HIV disease progression, but low CD4 counts increase susceptibility to opportunistic infections.
• Specific pathogens like Candida, Mycobacterium tuberculosis, and Pneumocystis carinii are common complications.
• The safety and efficacy of zidovudine in early pregnancy and for preventing infant transmission remain unclear.
• Cesarean section does not prevent peripartum HIV transmission.

Conclusions:

• Early recognition and management of opportunistic infections are vital for optimal outcomes in HIV-positive women.
• Antenatal screening for HIV should be population-based and supported by robust clinical care and counseling.
• Further research is needed on the safety of antiretroviral therapy during pregnancy and its role in preventing mother-to-child transmission.